New blood test developed by scientists in Australia could lead to routine screening for Alzheimer's disease.
They have identified blood-based signs of plaque in the brain that could alert doctors to the disease long before symptoms appear and irreversible brain damage has occurred, News.com.au reported.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
"Early detection is critical. It gives people a much better chance of receiving treatment before it's too late," researcher Dr Samantha Burnham from CSIRO's Preventative Health Flagship said.
Dr Burnham hopes the breakthrough will lead to routine age-based testing in five to 10 years.
Early diagnosis would also allow people to develop a care plan to reduce the burden on the patient and their family, she said.
She said that a blood test would be the ideal first stage to help identify people at risk before a diagnosis is confirmed with cognitive tests and brain scans.
The research has been published in the journal Molecular Psychiatry.
Source: ANI
Early diagnosis would also allow people to develop a care plan to reduce the burden on the patient and their family, she said.
She said that a blood test would be the ideal first stage to help identify people at risk before a diagnosis is confirmed with cognitive tests and brain scans.
The research has been published in the journal Molecular Psychiatry.
Source: ANI
Quiz On Alzheimer’s Disease
Alzheimer's disease (AD) is the most common form of dementia. Participate in this quiz to find out how much you know about this debilitating disease.
Advertisement
 Caring for Alzheimers disease patientsAlzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The slide show will show how patients need support and care as dementia progresses. | Advertisement
|
Suppressing Protein Regulator Activity can Stem Alzheimer's Disease Process
Removing toxic debris that accumulates in patients' brains by blocking activity of a regulator protein called CD33 could be a potential strategy.
Advertisement
Recommended Readings
Latest Research News
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.